Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Cash flows from operating activities
Net income	$ 7,352	$ 7,402
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization (including amortization of deferred financing costs)	2,616	2,409
Amortization of lease intangibles	1,178	1,237
Straight-lining of rental income	(1,446)	(346)
Loan discount accretion	(2,833)	(6,504)
Earnings of preferred equity investments		(83)
Distributions of income from preferred equity investments	97	59
(Income) losses of equity investments	(424)	1,355
Distributions of income from equity investments	2,764	1,166
Restricted cash held in escrows	(204)	1,501
Gain on sale of securities carried at fair value	(26)	(124)
Unrealized gain on securities carried at fair value	(4,932)	(886)
Unrealized gain on loan securities carried at fair value	(164)	(2,813)
Tenant leasing costs	(671)	(260)
Bad debt (recovery) expense	(127)	116
Net change in interest receivable	(7)	(226)
Net change in accounts receivable	(452)	149
Net change in accounts payable and accrued liabilities	(348)	63
Net cash provided by operating activities	2,373	4,215
Cash flows from investing activities
Investments in real estate	(2,469)	(3,293)
Investment in equity investments	(23,835)	(27,190)
Proceeds from sale of equity investments	250
Return of capital distribution from equity investments	38,100
Purchase of securities carried at fair value	(4,188)	(568)
Proceeds from sale of securities carried at fair value	4,302	19,915
Restricted cash held in escrows	(4,421)	(7,927)
Issuance and acquisition of loans receivable	(2,521)	(2,773)
Collection of loans receivable	357	170
Investment in other receivables		(7,000)
Net cash provided by (used in) investing activities	5,575	(28,666)
Cash flows from financing activities
Proceeds from mortgage loans payable	743	11,000
Principal payments of mortgage loans payable	(1,426)	(29,288)
Proceeds from revolving line of credit		27,324
Proceeds from issuance of Series D Preferred Shares	77,772
Payment of revolving line of credit	(40,000)	(18,899)
Proceeds from note payable		15,150
Restricted cash held in escrows	(10)	(629)
Deferred financing costs	(9)	(612)
Contribution from non-controlling interest	218	277
Distribution to non-controlling interest	(101)	(118)
Purchase of non-controlling interests	(400)
Issuance of Common Shares under Dividend Reinvestment Plan	133	680
Dividend paid on Common Shares	(5,369)	(4,392)
Dividend paid on Series D Preferred Shares	(925)
Dividend paid on Series C Preferred Shares		(59)
Net cash provided by financing activities	30,626	434
Net increase (decrease) in cash and cash equivalents	38,574	(24,017)
Cash and cash equivalents at beginning of period	40,952	45,257
Cash and cash equivalents at end of period	79,526	21,240
Supplemental Disclosure of Cash Flow Information
Interest paid	3,721	4,754
Taxes paid	161	18
Supplemental Disclosure on Non-Cash Investing and Financing Activities
Dividends accrued on Common Shares	5,371	4,402
Dividends accrued on Series C Preferred Shares		39
Capital expenditures accrued	1,583	122
Other receivables		(1,459)
Transfer to loan securities carried at fair value		662
Transfer from loans receivable	(2,938)	(662)
Transfer from preferred equity	(3,923)
Transfer to equity investment	$ 6,861